How to check ?
Windlas Biotech IPO Allotment Status
- Visit the registrar website Click 👉 Linkintime
- Click on ‘Select company’
- Company is selected, you will have to enter your PAN detail & the application number, or client ID.
- Enter the captcha and click ‘submit.
Windlas Biotech Ltd is amongst the top five players in the domestic pharmaceutical formulations Contract Development and Manufacturing Organization (“CDMO”) industry in India in terms of revenue.
With over two decades of experience in manufacturing both solid and liquid pharmaceutical dosage forms and significant experience in providing specialized capabilities, including, high potency, controlled substances and low-solubility, company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (“GMP”) with a focus on improved safety, efficacy and cost.
The Company’s EBITDA increased by 47.04% from Rs. 29.52 Crores in the nine months ended December 31, 2019 to Rs. 43.4 Crores in the nine months ended December 31, 2020.